- Japan Plans Stimulus as Export Slide Hurts
- Alcoa Loss Deeper than Expected; Sales Top Forecasts
- Treasury Looks Set to Extend TARP to Life Insurers
- Investors Request $1.7 Billion in TALF Loans
- GM In 'Intense' Prepartions for Possible Bankruptcy
- Bed, Bath & Beyond Shares Leap on Earnings Report
- Will Depression-Era Rule Right Topsy-Turvy Market?
- Cheap Eats in Hard Times: Popular Recession Foods
- Law Student Suing Peter Madoff Has New Adversary
- Pin the Tail on the Sell-Off
- The Little Bargain That Could...
- Lightning Round: Yahoo!, Boeing and More
- Lightning Round OT: Loews and More
- Off The Charts: Research In Motion
- Your First Move For Wednesday April 8th
- Web Extra: Fast & Furious Trades For Wednesday
- Earnings Edge: Trading Ahead of the Profit Report Deluge
- Return Of Uptick Rule
- Bidders' bounty? Storage unit auctions on the rise
- Economist Nouriel Roubini lashes out at CNBC host
- Island Air pilots to vote on contract
- Eclipse owners interested in buying assets
- Steelworkers protest India-made steel in Ill.
- Govt. approves plan for new spy satellites
- Embattled Boston newspaper hikes newsstand rates
- Chinese businessman indicted in Iran sale
- Ex-Qwest CEO Nacchio ordered to prison April 14
NEW YORK - Intel Corp. and General Electric Co. are jointly investing $250 million over the next five years to develop personalized home health care devices.
The companies envision products that will cut health care costs and help aging baby boomers and people with chronic illnesses remain in their homes by allowing doctors to monitor patients remotely.
Announcing the agreement Thursday, Intel Chief Executive Paul Otellini and GE CEO Jeffrey Immelt said their cooperation will help them jump quickly into a market they estimate will grow to $7.7 billion by 2012, from $3 billion this year.
The investment is one of "four or five big bets" that Intel, the computer chip maker, is making outside of PCs, Otellini said.
The Santa Clara, Calif.-based company has been developing health care products for the past four years, part of a long-running — though sometimes halting — effort to expand meaningfully into other areas. It has already introduced the Intel Health Guide, a home computer that monitors vital signs and allows doctors to communicate with patients over the Internet.
The new investment is tiny compared to Intel's multibillion-dollar research and development budget, American Technology Research analyst Doug Freedman said. But he expressed some optimism about Intel's ability to grow beyond PCs.
"I wouldn't put them in the camp of, `They failed before so they're going to fail again,'" he said.
Fairfield, Conn.-based GE, which is taking over marketing and distribution of Intel's Health Guide, has its own health care products as well. The company's GE Quiet Care system monitors patients' vital signs remotely using electronic sensors.
Intel shares rose 67 cents, 4.5 percent, to close at $15.70 as the broader market also posted big gains. GE shares rose 57 cents, 5.6 percent, to $10.74.



